Drugs | FDA - U.S. Food and Drug Administration
Drugs@FDA Find information about most FDA-approved prescription, generic, and over-the-counter drug products. Drug Shortages Find information about drug shortages caused by manufacturing and ...
Information for Consumers and Patients | Drugs | FDA
Drug Information for Patients and ConsumersBiosimilars Basics for Patients Using Fat-Dissolving Injections That Are Not FDA Approved Can Be Harmful What You Should Know about Eye Drops …
Find Information about a Drug | FDA
Information on FDA-approved drugs released for sale on the market, such as dosage, side effects, and disposal methods
Drugs | FDA
Consumer articles about over-the-counter and prescription drugs.
Novel Drug Approvals for 2025 | FDA
Dec 4, 2025 · Innovative drugs often mean new treatment options for patients and advances in health care for the American public.
Drug Approvals and Databases | FDA
Sep 24, 2025 · CDER highlights key Web sites. Web page provides quick links to everything from acronyms to wholesale distributor and third-party logistics providers reporting.
Information for Health Care Professionals | Drugs | FDA
Health care professionals play a critical role in ensuring safe and effective medication use. The Center for Drug Evaluation and Research (CDER) provides compressive resources to support informed ...
Approved Drugs: Questions and Answers | FDA
How is a medicine approved by FDA? Drug companies seeking approval to sell a drug in the United States must test it. First, the drug company or sponsor performs laboratory and animal tests to ...
Drug Safety and Availability | FDA
Information for consumers and health professionals on new drug warnings and other safety information, drug label changes, and shortages of medically necessary drug products.
FDA approves datopotamab deruxtecan-dlnk for unresectable or …
On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc.), a Trop-2-directed antibody and topoisomerase inhibitor conjugate, …